Cronos Group (CRON) Reports Q1 EPS of $0.20

Go back to Cronos Group (CRON) Reports Q1 EPS of $0.20

Cronos Group Reports 2020 First Quarter Results

May 8, 2020 7:31 AM EDT

Fermented target cannabinoid, CBGA, using cannabinoid strains at Cronos Fermentation R&D labs

Successfully completed first dried flower shipment to Israel, as Cronos Israel moves closer to entering the medical cannabis market with PEACE NATURALS branded products

Natuera completes key operational milestones and begins test exports to the U.S. hemp-derived market

TORONTO, May 08, 2020 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (Cronos Group or the Company), today announces its 2020 first quarter business... More